S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Secret Bull Market Starts in This Unusual Sector (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Biden’s $374B Giveaway Into This Sector (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Urgent alert: open this for a huge profit potential (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Secret Bull Market Starts in This Unusual Sector (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Biden’s $374B Giveaway Into This Sector (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Urgent alert: open this for a huge profit potential (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Secret Bull Market Starts in This Unusual Sector (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Biden’s $374B Giveaway Into This Sector (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Urgent alert: open this for a huge profit potential (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Secret Bull Market Starts in This Unusual Sector (Ad)
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
Biden’s $374B Giveaway Into This Sector (Ad)
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
Urgent alert: open this for a huge profit potential (Ad)
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
Free Trial
NASDAQ:GRNA

GreenLight Biosciences (GRNA) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free GRNA Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$0.30
▼
$0.30
50-Day Range
$0.30
▼
$0.30
52-Week Range
$0.18
▼
$5.90
Volume
732 shs
Average Volume
486,986 shs
Market Capitalization
$45.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
GRNA stock logo

About GreenLight Biosciences Stock (NASDAQ:GRNA)

FUNR manufactures and sells all-natural juice beverages. Its products include pomegranate cranberry, wild berry and passion fruit-orange. The company was founded by Alex C. Procopio on July 22, 1980 and is headquartered in Las Vegas, NV.

GRNA Stock News Headlines

December 20, 2023 | bbc.com
Splashdown Quaywest gets green light for £3m upgrade
September 28, 2023 | bbc.com
Broadwalk Shopping Centre redevelopment given green light
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
September 19, 2023 | forbes.com
Greenlight Family Cash Card 2023 Review
July 24, 2023 | finanznachrichten.de
GreenLight Biosciences: GreenLight Announces Completion of Merger with Fall Line Endurance Fund
July 24, 2023 | finance.yahoo.com
GreenLight Announces Completion of Merger with Fall Line Endurance Fund
July 20, 2023 | finance.yahoo.com
GreenLight Biosciences Announces Expiration of Tender Offer Period for Outstanding Shares
June 13, 2023 | bizjournals.com
RNA company to lay off 96 employees in Lexington
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
June 5, 2023 | benzinga.com
GRNA ALERT: Levi & Korsinsky, LLP Announces an Investigation of Greenlight Biosciences
June 1, 2023 | bizjournals.com
RTP biotech went public a year ago. Now, it's being acquired
June 1, 2023 | bizjournals.com
The Petri Dish: GreenLight to go private; C4 licenses cancer drug for $392M
May 31, 2023 | benzinga.com
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating GreenLight Biosciences Holdings Buyout
May 30, 2023 | benzinga.com
Shareholder Alert: Ademi LLP investigates whether GreenLight Biosciences Holdings, PBC has obtained a Fair Price in its transaction with Fall Line
May 30, 2023 | msn.com
GreenLight Biosciences trades 36% higher on merger agreement with Fall Line Endurance Fund
May 30, 2023 | finance.yahoo.com
GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by Fall Line Endurance Fund for Go-Private Transaction
May 12, 2023 | msn.com
Recap: GreenLight Biosciences Q1 Earnings
May 12, 2023 | msn.com
GreenLight Biosciences GAAP EPS of -$0.19 beats by $0.08, revenue of $3.82M beats by $3.32M
May 11, 2023 | finance.yahoo.com
GreenLight Biosciences Announces First Quarter 2023 Financial Results and Highlights Recent Company Progress
April 12, 2023 | finance.yahoo.com
GreenLight Biosciences Releases Inaugural Sustainability Report
April 1, 2023 | seekingalpha.com
GreenLight Biosciences draws private equity interest; up 10%
March 30, 2023 | finance.yahoo.com
GreenLight Biosciences Holdings Confirms Receipt of Indication of Interest from Fall Line
March 28, 2023 | finance.yahoo.com
GreenLight Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results
March 9, 2023 | finance.yahoo.com
GreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates at Human Health R&D Day
March 7, 2023 | finance.yahoo.com
GreenLight Biosciences Outlines Development Strategy and Highlights Portfolio Updates at Plant Health R&D Day
March 4, 2023 | bbc.co.uk
Greenlight Screenwriting Lab
March 1, 2023 | finance.yahoo.com
GreenLight Biosciences to Host R&D Day Series on Plant and Human Health Development Strategy
See More Headlines
Receive GRNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GreenLight Biosciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/19/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:GRNA
CUSIP
N/A
CIK
1822691
Web
www.eiacorp.com
Phone
(760) 809-8079
Fax
N/A
Employees
280
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($1.14)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-167,050,000.00
Net Margins
-1,521.00%
Pretax Margin
-1,510.44%
Return on Equity
-374.26%
Return on Assets
-122.78%

Debt

Debt-to-Equity Ratio
0.49
Current Ratio
1.21
Quick Ratio
1.21

Sales & Book Value

Annual Sales
$10.20 million
Price / Sales
4.45
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.32 per share
Price / Book
0.94

Miscellaneous

Outstanding Shares
151,681,000
Free Float
105,722,000
Market Cap
$45.43 million
Optionable
Not Optionable
Beta
1.44
Elon Musk's Next Move Cover
Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

This page (NASDAQ:GRNA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
SHOCKING Crypto Leak…
Crypto 101 Media
The #1 Crypto for 2024
InvestorPlace
1970’s computer coder issues shocking A.I. warning
TradeSmith
Top 5 AI Stocks to Buy for 2024
Market Moving Trends